Form 8-K - Current report:
SEC Accession No. 0001558370-25-000148
Filing Date
2025-01-13
Accepted
2025-01-13 07:00:16
Documents
47
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20250113x8k.htm   iXBRL 8-K 39006
2 EX-99.1 acrs-20250113xex99d1.htm EX-99.1 49794
3 GRAPHIC acrs-20250113xex99d1g001.jpg GRAPHIC 128057
4 GRAPHIC acrs-20250113xex99d1g002.jpg GRAPHIC 334919
5 GRAPHIC acrs-20250113xex99d1g003.jpg GRAPHIC 215690
6 GRAPHIC acrs-20250113xex99d1g004.jpg GRAPHIC 147005
7 GRAPHIC acrs-20250113xex99d1g005.jpg GRAPHIC 100848
8 GRAPHIC acrs-20250113xex99d1g006.jpg GRAPHIC 82900
9 GRAPHIC acrs-20250113xex99d1g007.jpg GRAPHIC 172053
10 GRAPHIC acrs-20250113xex99d1g008.jpg GRAPHIC 74729
11 GRAPHIC acrs-20250113xex99d1g009.jpg GRAPHIC 126224
12 GRAPHIC acrs-20250113xex99d1g010.jpg GRAPHIC 138793
13 GRAPHIC acrs-20250113xex99d1g011.jpg GRAPHIC 131895
14 GRAPHIC acrs-20250113xex99d1g012.jpg GRAPHIC 93321
15 GRAPHIC acrs-20250113xex99d1g013.jpg GRAPHIC 73579
16 GRAPHIC acrs-20250113xex99d1g014.jpg GRAPHIC 123247
17 GRAPHIC acrs-20250113xex99d1g015.jpg GRAPHIC 79009
18 GRAPHIC acrs-20250113xex99d1g016.jpg GRAPHIC 126543
19 GRAPHIC acrs-20250113xex99d1g017.jpg GRAPHIC 142111
20 GRAPHIC acrs-20250113xex99d1g018.jpg GRAPHIC 122006
21 GRAPHIC acrs-20250113xex99d1g019.jpg GRAPHIC 126014
22 GRAPHIC acrs-20250113xex99d1g020.jpg GRAPHIC 84595
23 GRAPHIC acrs-20250113xex99d1g021.jpg GRAPHIC 135635
24 GRAPHIC acrs-20250113xex99d1g022.jpg GRAPHIC 115999
25 GRAPHIC acrs-20250113xex99d1g023.jpg GRAPHIC 95518
26 GRAPHIC acrs-20250113xex99d1g024.jpg GRAPHIC 138672
27 GRAPHIC acrs-20250113xex99d1g025.jpg GRAPHIC 139708
28 GRAPHIC acrs-20250113xex99d1g026.jpg GRAPHIC 132433
29 GRAPHIC acrs-20250113xex99d1g027.jpg GRAPHIC 135297
30 GRAPHIC acrs-20250113xex99d1g028.jpg GRAPHIC 129610
31 GRAPHIC acrs-20250113xex99d1g029.jpg GRAPHIC 98846
32 GRAPHIC acrs-20250113xex99d1g030.jpg GRAPHIC 74483
33 GRAPHIC acrs-20250113xex99d1g031.jpg GRAPHIC 139657
34 GRAPHIC acrs-20250113xex99d1g032.jpg GRAPHIC 90496
35 GRAPHIC acrs-20250113xex99d1g033.jpg GRAPHIC 135031
  Complete submission text file 0001558370-25-000148.txt   5961930

Data Files

Seq Description Document Type Size
36 EX-101.SCH acrs-20250113.xsd EX-101.SCH 3135
37 EX-101.LAB acrs-20250113_lab.xml EX-101.LAB 15916
38 EX-101.PRE acrs-20250113_pre.xml EX-101.PRE 10223
49 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20250113x8k_htm.xml XML 4840
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 25524730
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)